One potential way to make quitting easier and more fun is by switching to pre-made hemp-ettes that are rich in cannabidiol (CBD), marijuana’s secondary active ingredient. In a small 2013 study, CBD users cut cigarette intake by 40%.
CBD comes from the cannabis plant, but it doesn’t make you feel high like pot’s main active ingredient, THC. Instead, studies indicate CBD can reduce social anxiety, inflammation, and create a calm feeling without much euphoria. CBD is also empowering plenty of smokers to step down from highly addictive and carcinogenic tobacco. The World Health Organization concludes CBD is not habit-forming. And NIDA-funded research failed to find an association between cannabis smoking and lung disease or cancer. These CBD-rich hemp-ettes help people quit by offering a similar experience for when intense cravings hit, such as during social occasions, right after sex, or other times when you might habitually light up a cigarette. A 2019 review of early clinical studies finds that “animal and human studies suggest that [CBD has] the potential to reduce craving and relapse in abstinent substance users, by impairing reconsolidation of drug-reward memory, salience of drug cues, and inhibiting the reward-facilitating effect of drugs.” A 2018 double-blind, placebo-controlled study of a mega-dose of CBD (800 mg) for tobacco cessation found that it helped quitters pay less attention to tobacco around them. That is, CBD “reduced salience and pleasantness of cigarette cues”, but didn’t lessen cravings or withdrawal. Federal cannabis prohibition stymies further research. But we are hearing good things from clients utilizing Hemp-ettes to comfortably reduce and eliminate tobacco cigarettes. You may purchase them here: https://www.weebly.com/editor/main.php#/store/products/125
0 Comments
CBG has been found to act on very specific physiological systems and problems, and results for medicinal use are promising:
One of the most popular methods of administering cannabidiol is through CBD edibles. It is a simple and easy way to get your ideal dosage, and there are so many options. CBD is a compound found in hemp that does not have the same psychoactive effects as THC. Since it is not a marijuana product, no medical marijuana card is required. Many users find it helpful as a method of treating pain, anxiety, and more.
Take CBD Through Candies If you have a sweet tooth, these CBD edibles are sure to catch your eye. The packaging on all candy options clearly lists the amount of CBD in milligrams per piece so that you can keep close track of your dosage with each delicious bite. The choices include sour gummy bears with 10 mg per piece and caramels with 15 mg per piece. If you are shopping for friends and loved ones, consider buying them gift cards so they can choose their favorite candy or other methods of using CBD. Beverages Infused with CBD These exciting options are perfect for those who love to curl up with a cup of tea at the end of a long day. We offer three varieties of CBD infused tea in packages of 1.5 oz that make approximately 12 cups. Passion Green is fruity and refreshing, while the Golden Chai option is spiced and soothing. Raspberry Daze is a rooibos with a fruity tinge. If tea isn’t your usual drink, try the CBD Nano Water. The bottled water measures CBD in nanograms, which allows for better, more thorough absorption. Lozenges, Oils, and Capsules These options are a convenient, no-nonsense method of ingesting CBD. Lozenges come in 50 mg strength and dissolve in the mouth to provide more instant relief. CBD capsules come in a range of strengths, with 15 mg, 25 mg, and 50 mg capsules available. They can be taken the same way as other supplements, which makes them easy to work into a daily routine. The oil options are very concentrated and are taken sublingually. The droppers offer precision doses, which should be held beneath the tongue for a minute to allow for maximum absorption. These ingestibles are efficient and especially helpful if you know your ideal dose. The CBD Store AZ has been providing reliable methods of CBD usage for more than five years. With options ranging from nasal sprays to edibles, you are sure to find one that appeals to you. We offer classes on CBD use and administration for up to six people at a time, so new users can learn about the benefits of CBD and how to find the best dosage for the desired effects. The very best part of being involved with CBD is how many people we help with their discomforts. It truly is such an amazing feeling, when a client returns, usually bringing friends, and with a sparkle in their eye--thanking you for saving their life. Recently our staff at the store assisted a woman who has had migraines her entire life. She was skeptical, but desperate and so she left with her CBD products after learning how CBD may be beneficial for her. She returned a week later, with friend, and exclaimed that Yoshi, our wonderful CBD expert, saved her life. With tears in her eyes, she explained that she has not had a migraine in a week and how she has had migraines her entire life on a weekly basis. She was so appreciative and excited about life that it made me feel blessed for this truly amazing compound. I have seen the results from many who suffer from migraines, but she touched my heart with her sharing of her life long struggle and how we were able to assist. Her story left me more determined to reach those suffering. Clinical studies and scientific research are rare, but I dug up the following to help people with their decision to try CBD for migraines.
What Does the Research Actually Say? The common thread you can find throughout the existing scientific research on this subject is that CBD oil can improve some migraine symptoms for most people. In 2016, Pharmacotherapy published a study showing how the frequency of migraine headaches dropped from 10.4 headaches a month to 4.6 in a group of 121 medical marijuana users. Cannabis and Cannabinoid Research published a review last year showing a clear history of cannabinoid use in the treatment and reduction of migraines. Uses and Safety Previous research studies have shown that CBD oil, unlike THC, does not cause a euphoric high or psychotropic effects, and is typically less controversial and safer for medicinal use. CBD oil has been shown, in a limited number of studies, to be effective in the treatment of many disorders, including diabetes, arthritis, multiple sclerosis, and migraines. A recent study discovered that the type of cannabis that CBD is composed of is very well tolerated and safe in humans. The researchers who conducted the study reported that when the type of cannabis with THC was given to study subjects, there was an increased heart rate, anxiety, and psychotic symptoms noted; but, when CBD oil—lacking THC—was given, there were no side effects (including psychotic symptoms). ConclusionsWhile there is a lot of good to say about the use of CBD oil as a migraine treatment, there simply is not enough evidence to say conclusively that it will be 100% effective 100% of the time for 100% of the population. Perhaps, in time, laws will change and more research can be done to develop CBD oil as a reliable migraine treatment, but we are simply not there yet. What the evidence does show, however, is that CBD oil can absolutely help relieve some symptoms related to migraines. “Most diabetic patients describe moderate to severe pain symptoms whose pharmacological treatment is palliative and poorly effective”, states the study’s abstract. “Cannabidiol (CBD) has shown promising results in painful conditions.” With this in mind, researchers “aimed to investigate the potential antinociceptive effect of CBD over the mechanical allodynia in streptozotocin-induced diabetic (DBT) rats, as well as its involved mechanisms.”
For the study, “Wistar adult male diabetic rats were treated acutely or sub-chronically (for 14 days) with CBD (0.1, 0.3 or 3 mg/Kg, intraperitoneal; i.p.) and had their mechanical threshold assessed using the electronic Von Frey. ” Acute treatment with CBD (at doses of 0.3 and 3 mg/Kg) “exerted a significant anti-allodynic effect, which is not associated with locomotor impairment. “The antinociceptive effect of CBD (3 mg/Kg) was not altered by the pre-treatment with CB1 or CB2 receptor antagonists (AM251 and AM630; respectively; both at a dose of 1 mg/kg, i.p.) nor by glycine receptor antagonist (strychnine hydrochloride, 10 μg/rat, intrathecal, i.t.).” “However,” the study states, “this effect was completely prevented by the pre-treatment with the selective 5-HT1A receptor antagonist WAY 100135 (3 μg/rat, i.t.). Sub-chronic treatment with CBD (0.3 or 3 mg/Kg) induced a sustained attenuation of the mechanical allodynia in DBT rats.” DBT rats “presented significantly lower spinal cord levels of serotonin, which was prevented by the daily treatment with CBD (0.3 mg/Kg).” Taken together, the data “suggest that CBD may be effective in the treatment of painful diabetic neuropathy and this effect seems to be potentially mediated by the serotonergic system activation through 5-HT1A receptors.” The full abstract can be found below: Most diabetic patients describe moderate to severe pain symptoms whose pharmacological treatment is palliative and poorly effective. Cannabidiol (CBD) has shown promising results in painful conditions. Then, we aimed to investigate the potential antinociceptive effect of CBD over the mechanical allodynia in streptozotocin-induced diabetic (DBT) rats, as well as its involved mechanisms. Wistar adult male diabetic rats were treated acutely or sub-chronically (for 14 days) with CBD (0.1, 0.3 or 3 mg/Kg, intraperitoneal; i.p.) and had their mechanical threshold assessed using the electronic Von Frey. Acute treatment with CBD (at doses of 0.3 and 3 mg/Kg) exerted a significant anti-allodynic effect, which is not associated with locomotor impairment. The antinociceptive effect of CBD (3 mg/Kg) was not altered by the pre-treatment with CB1 or CB2 receptor antagonists (AM251 and AM630; respectively; both at a dose of 1 mg/kg, i.p.) nor by glycine receptor antagonist (strychnine hydrochloride, 10 μg/rat, intrathecal, i.t.). However, this effect was completely prevented by the pre-treatment with the selective 5-HT1A receptor antagonist WAY 100135 (3 μg/rat, i.t.). Sub-chronic treatment with CBD (0.3 or 3 mg/Kg) induced a sustained attenuation of the mechanical allodynia in DBT rats. DBT rats presented significantly lower spinal cord levels of serotonin, which was prevented by the daily treatment with CBD (0.3 mg/Kg). Taken together, our data suggest that CBD may be effective in the treatment of painful diabetic neuropathy and this effect seems to be potentially mediated by the serotonergic system activation through 5-HT1A receptors. This abstract, and a link to the full text, can be found on the National Institute of Health’s website at the following link: https://www.ncbi.nlm.nih.gov/pubmed/30898678 |
Archives
October 2022
Categories |